Is the Shingles Vaccine (Shingrix) Covered by OHIP in Ontario?

Many Ontarians use the terms OHIP and ODB interchangeably, but they are different programs. OHIP (Ontario Health Insurance Plan) covers physician visits, hospital stays, and most medical procedures — but not prescription drugs or most vaccines. The Ontario Drug Benefit (ODB) program is a separate provincial program that covers prescription drug costs for eligible residents including seniors, social assistance recipients, and people with high drug costs relative to their income.

Shingrix is NOT covered by OHIP. However, it IS on the ODB formulary for eligible seniors. If you are 65 or older and enrolled in ODB, you can receive Shingrix at a significantly reduced cost — typically just the standard ODB co-pay ($2.00–$6.11 per dose depending on your ODB category). For everyone else, private insurance or out-of-pocket payment applies.

Yes — the overwhelming consensus among infectious disease specialists, NACI (National Advisory Committee on Immunization), and public health authorities is that Shingrix is worth the cost for adults 50 and older, even without insurance coverage.

Here is why: Shingrix is over 90% effective at preventing shingles in adults 50–69, and over 89% effective in adults 70+. More importantly, it is over 89% effective at preventing post-herpetic neuralgia (PHN) — the severe, often debilitating nerve pain that can persist for months or years after a shingles episode. PHN is notoriously difficult to treat and can significantly impair quality of life.

Shingles itself carries a lifetime risk of approximately 1 in 3 Canadians. The risk rises sharply after age 50 and with any immunosuppression. A shingles episode typically requires antiviral medication ($100–$200+), multiple physician visits, and potentially weeks or months of pain management — costs that easily exceed the price of two doses of Shingrix.